Broad Institute
JUNE 21, 2023
said Vamsi Mootha , senior author of the study, an institute member at the Broad, professor of systems biology and medicine at Harvard Medical School, and professor of molecular biology at Massachusetts General Hospital. Mootha’s lab has been studying hypoxia as a potential treatment for rare neurological diseases since 2016.
Broad Institute
APRIL 25, 2024
Christian Happi Christian Happi However, in other parts of West Africa , Ebola was spreading, infecting nearly 29,000 people and killing more than 11,000 before the outbreak was contained in 2016. These are people on the frontlines,” Happi said. We’re empowering them to be more effective at the job they do on a daily basis.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
FEBRUARY 22, 2021
Born in 1970, the British and American research scientist has been Director of the Department of Microbiome Research at the Max Planck Institute for Developmental Biology in Tübingen since 2016. Before, she was associate professor at Cornell University in the Department of Molecular Biology and Genetics.
Elrig
APRIL 29, 2024
Jasmine has a background in neuroscience and genetic manipulation, with early works focused on using a combined structural and molecular biology approach to assess disease-associated proteins implicated in Alzheimer’s disease. Bioinformatics is all about bringing together different areas of knowledge.
The Pharma Data
NOVEMBER 18, 2021
Bristol Myers Squibb has annually held the Golden Ticket contest since it began in Cambridge in 2016 for promising biotech launch-ups pursuing exploration in new target identification, medicine delivery, discovery technology platforms or translational R&D in a variety of remedial exploration fields.
Drug Target Review
AUGUST 29, 2024
He holds multiple utility and design patents for scientific technologies and has authored various peer-reviewed manuscripts in the fields of bacteriology, virology, immunology, molecular biology, and cancer immunotherapy.
Drug Target Review
JULY 1, 2024
was founded in 2016 to develop safer, non-opioid therapies for acute and chronic pain. Dr Hernan Bazan received a BS in molecular biology from Vanderbilt University and has spent two years in medical school as a Howard Hughes Medical Institute (HHMI) Research Scholar at the NIH. South Rampart Pharma, Inc.
Expert insights. Personalized for you.
98 
Let's personalize your content